The role of adenosine receptors A2A and A2B signaling in renal fibrosis.
The role of adenosine receptors A2A and A2B signaling in renal fibrosis.
复制标题
DOI:
10.1038/ki.2014.244
复制
发表时间:
2014-10
影响因子:
19.6
通讯作者:
Veena Roberts;P. Cowan;S. Alexander;S. Robson;K. Dwyer
中科院分区:
文献类型:
--
作者:
Veena Roberts;P. Cowan;S. Alexander;S. Robson;K. Dwyer
Renal fibrosis, the key histopathological lesion in the development and progression of chronic kidney disease (CKD), has been the focus of much research in recent decades. The growing burden of CKD in both developed and developing nations highlights a need for novel therapies to halt the progression of renal disease. Insights into the pathogenesis of renal fibrosis and the key cellular and molecular mediators have been critical in the process of identifying potential targets of therapy. Adenosine signaling is an innate biological autocrine and paracrine cellular signaling pathway involving several key mediators: ectonucleotidases, adenosine, and adenosine receptors. Short-term activation of the adenosine A2Aand A2Breceptors decreases inflammation, which precedes renal fibrosis. However, in conditions of persistent, excessive adenosine exposure, such as in patients born with adenosine deaminase (ADA) deficiency, adenosine signaling via A2Breceptor promotes renal fibrosis, as seen in chronic inflammation. This review will describe the increasingly recognized complex role of adenosine signaling in the development of renal fibrosis. We will speculate how the knowledge gained may be employed in the search for more effective therapies based on these complex signaling pathways.